Dolat Capital recommended accumulate rating on Bajaj Consumer Care with a target price of Rs 359 in its research report dated April 10, 2019.
Dolat Capital's research report on Bajaj Consumer Care
The company reported a topline growth of 10.9% in Q4FY19, driven by a 6% volume growth during the quarter. The company maintained its volume performance posted in Q3FY19. Despite RM inflation, the company was able to restrict margin fall to 80bps was encouraging considering 30%+ margins, highest margins in the consumer space. The ADHO brand, continues to gain volume and value market share. Strong volume growth in modern trade (+21%) and general trade (+11%) along with +56% growth in IB helped sales growth to accelerate during the quarter. However, 15% decline in CSD channels remains a weak spot. Going ahead, we believe that the rural areas would benefit from stimulus and general elections. However, below average monsoon expectation remains a risk for rural performance. As GM have declined during the quarter, we believe the company would increase prices in a calibrated manner to mitigate cost increases. However, new product launches may accelerate A&P spend.
Outlook
We marginally revise our FY20E and FY21E earnings to ` 16.5 and ` 17.9, respectively, to factor in expected increase in A&P spends. Valuing the stock at 20x (23x earlier) FY21E to arrive at a TP of ` 359. Considering recent correction in the stock price we are upgrading the rating to Accumulate.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Read More
